These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Thrombosis in children with acute lymphoblastic leukemia treated at a tertiary care center in Lebanon: revisiting the role of predictive models. Al-Aridi C; Abboud MR; Saab R; Eid D; Jeha S; Chan AK; Muwakkit SA Pediatr Hematol Oncol; 2011 Nov; 28(8):676-81. PubMed ID: 21787123 [TBL] [Abstract][Full Text] [Related]
44. Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group. Rau RE; Dreyer Z; Choi MR; Liang W; Skowronski R; Allamneni KP; Devidas M; Raetz EA; Adamson PC; Blaney SM; Loh ML; Hunger SP Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29090524 [TBL] [Abstract][Full Text] [Related]
46. The impact of prophylactic fresh-frozen plasma and cryoprecipitate on the incidence of central nervous system thrombosis and hemorrhage in children with acute lymphoblastic leukemia receiving asparaginase. Abbott LS; Deevska M; Fernandez CV; Dix D; Price VE; Wang H; Parker L; Yhap M; Fitzgerald C; Barnard DR; Berman JN Blood; 2009 Dec; 114(25):5146-51. PubMed ID: 19822902 [TBL] [Abstract][Full Text] [Related]
47. Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance. Chen SH Pediatr Neonatol; 2015 Oct; 56(5):287-93. PubMed ID: 25603726 [TBL] [Abstract][Full Text] [Related]
48. Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study. Liu WJ; Wang H; Wang WD; Zhu MY; Liu CC; Wang JH; Lu Y Sci Rep; 2016 Dec; 6():39463. PubMed ID: 28000713 [TBL] [Abstract][Full Text] [Related]
49. L-asparaginase induced intracranial haemorrhage in acute lymphoblastic leukemia. Lim HL; Teo CP; Wong K; Kueh YK Singapore Med J; 1998 Feb; 39(2):76-8. PubMed ID: 9652181 [TBL] [Abstract][Full Text] [Related]
51. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia. Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027 [TBL] [Abstract][Full Text] [Related]
52. Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study. Athale UH; Laverdiere C; Nayiager T; Delva YL; Foster G; Thabane L; Chan AK BMC Cancer; 2017 May; 17(1):313. PubMed ID: 28472942 [TBL] [Abstract][Full Text] [Related]
53. Reducing venous thrombosis with antithrombin supplementation in patients undergoing treatment for ALL with Peg-asparaginase-A real world study. George G; Rezazadeh A; Zook F; Pearl N; McCoy C; Carlson K; Runaas L; Abedin S; Guru Murthy GS; Michaelis LC; Atallah E; Baumann-Kreuziger L Leuk Res; 2020 Jul; 94():106368. PubMed ID: 32442786 [No Abstract] [Full Text] [Related]
54. Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider. El-Khoury H; Saifi O; Haddad S; Chahrour M; Ghanem KM; Mubarak Y; Tamim H; Makki M; Zakka C; Chan AK; Mahfouz R; Tarek N; El-Solh H; Abboud MR; Saab R; Muwakkit SA Pediatr Blood Cancer; 2021 Nov; 68(11):e29210. PubMed ID: 34327817 [TBL] [Abstract][Full Text] [Related]
55. Outcome of adults with acute lymphoblastic leukemia treated with a pediatric-inspired therapy: a single institution experience. Ruiz-Delgado GJ; Macías-Gallardo J; Lutz-Presno JA; Montes-Montiel M; Ruiz-Argüelles GJ Leuk Lymphoma; 2011 Feb; 52(2):314-6. PubMed ID: 21054153 [No Abstract] [Full Text] [Related]
56. Toxicity profile of repeated doses of PEG-asparaginase incorporated into a pediatric-type regimen for adult acute lymphoblastic leukemia. Aldoss I; Douer D; Behrendt CE; Chaudhary P; Mohrbacher A; Vrona J; Pullarkat V Eur J Haematol; 2016 Apr; 96(4):375-80. PubMed ID: 26095294 [TBL] [Abstract][Full Text] [Related]
57. [The feasibility of Erwinia asparaginase for pediatric patients who developed an allergic reaction to E.coli asparaginase during treatment of acute lymphoblastic leukemia]. Takahashi H; Koh K; Kato M; Isobe K; Yasui N; Mori M; Akiyama K; Kikuchi A; Hanada R Rinsho Ketsueki; 2013 Apr; 54(4):370-7. PubMed ID: 23666219 [TBL] [Abstract][Full Text] [Related]
58. Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Abshire TC; Pollock BH; Billett AL; Bradley P; Buchanan GR Blood; 2000 Sep; 96(5):1709-15. PubMed ID: 10961868 [TBL] [Abstract][Full Text] [Related]
59. Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age. Rank CU; Wolthers BO; Grell K; Albertsen BK; Frandsen TL; Overgaard UM; Toft N; Nielsen OJ; Wehner PS; Harila-Saari A; Heyman MM; Malmros J; Abrahamsson J; Norén-Nyström U; Tomaszewska-Toporska B; Lund B; Jarvis KB; Quist-Paulsen P; Vaitkevičienė GE; Griškevičius L; Taskinen M; Wartiovaara-Kautto U; Lepik K; Punab M; Jónsson ÓG; Schmiegelow K J Clin Oncol; 2020 Jan; 38(2):145-154. PubMed ID: 31770057 [TBL] [Abstract][Full Text] [Related]
60. Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and Outcome. Hanbali A; Kotb A; El Fakih R; Alfraih F; Ahmed SO; Shaheen M; Hashmi S; Alhayli S; Alahmari A; Riash MA; Rasheed W; Alzahrani H; Alsharif F; Chaudhri N; Almohareb F; Aljurf M Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):670-677. PubMed ID: 31377206 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]